Africa Digital Media Awards

Global site navigation

Local editions

Roche says will invest $50 bn in US over next five years
Economy

Roche says will invest $50 bn in US over next five years

by  AFP 1 min read
Swiss pharma giant Roche has its headquarters in Basel
Swiss pharma giant Roche has its headquarters in Basel. Photo: Fabrice COFFRINI / AFP
Source: AFP

Don't miss out! Join Legit.ng's Sports News channel on WhatsApp now!

Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five years.

"These investments further strengthen Roche's already significant US footprint with 13 manufacturing and 15 R&D sites across the pharmaceutical and diagnostics divisions, and are expected to create more than 12,000 new jobs," a company statement said.

The firm already has plants in the United States, and said the move would help expand capacity at sites in Kentucky, Indiana, New Jersey, Oregon and California.

"Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US," said Roche Group chief executive Thomas Schinecker.

"Our investments of $50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the US and around the world."

Source: AFP

Authors:
AFP avatar

AFP AFP text, photo, graphic, audio or video material shall not be published, broadcast, rewritten for broadcast or publication or redistributed directly or indirectly in any medium. AFP news material may not be stored in whole or in part in a computer or otherwise except for personal and non-commercial use. AFP will not be held liable for any delays, inaccuracies, errors or omissions in any AFP news material or in transmission or delivery of all or any part thereof or for any damages whatsoever. As a newswire service, AFP does not obtain releases from subjects, individuals, groups or entities contained in its photographs, videos, graphics or quoted in its texts. Further, no clearance is obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP material. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP material.

Hot: